| Financial Year |
March 31 2023 |
| Monetary Funds |
518,496,230.93 |
| Held-for-trading Financial Assets |
274,403,145.01 |
| Notes Receivable |
142,213,492.01 |
| Accounts Receivable |
953,062,324.29 |
| Advances to Suppliers |
48,971,242.11 |
| Other Receivables |
33,155,551.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
874,206,608.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,095,646.72 |
| Total Current Assets |
3,018,839,786.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,268,682.69 |
| Investment Properties |
-- |
| Fixed Assetes |
1,174,445,139.42 |
| Under-construction Projects |
828,049,534.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,827,875.16 |
| R&D expenses |
-- |
| Goodwill |
232,594,367.47 |
| Long-Term Deferred and Prepaid Expenses |
31,488,002.49 |
| Deferred Income Tax Assets |
37,912,539.09 |
| Other Non-Current Assets |
151,141,997.85 |
| Sub-Total of Non-Current Assets |
2,601,989,562.74 |
| Total Assets |
5,620,829,349.40 |
| Short-Term Loans |
585,298,964.53 |
| Trading Financial liabilities |
-- |
| Notes Payable |
241,157,046.38 |
| Accounts Payable |
648,028,403.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,333,611.09 |
| Taxes Payable |
39,401,071.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,552,513.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
178,603,921.34 |
| Other Current Liabilities |
19,113,090.07 |
| Sub-Total of Current Liabilities |
1,938,071,876.18 |
| Long-term Loans |
452,660,743.25 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,176,377.05 |
| Deferred Income Tax Liabilities |
9,060,939.01 |
| Other Non-Current Liabilities |
108,787,679.04 |
| Sub-Total of Non-Current Liabilities |
653,345,509.10 |
| Total Liabilities |
2,591,417,385.28 |
| Paid-In Capital(Or Share Stock) |
507,537,461.00 |
| Capital Surplus |
1,155,945,834.79 |
| Surplus Reserve |
119,368,840.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,250,238,723.87 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,029,411,964.12 |
| Owner's Equity（Stockholder's Equity） |
3,029,411,964.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,620,829,349.40 |
